Dr. Uri Ladabaum is a Professor of Medicine (Gastroenterology and Hepatology) and the Director of the Gastrointestinal Cancer Prevention Program at Stanford University Medical Center.
He is a nationally recognized expert in colorectal cancer screening, including evaluation of the economic impact and cost-effectiveness of screening strategies. His research program spans a range of methods and approaches, including epidemiological studies, observational and interventional clinical studies, decision analyses, and systematic reviews.
- Computer-aided Detection of Polyps Does Not Improve Colonoscopist Performance in a Pragmatic Implementation Trial
- Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45-49 Years vs Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines
- Adenoma and Serrated Lesion Detection by Colonoscopy Indication: The ADR-ESS (ADR Extended to all Screening/Surveillance) Score
- Colorectal Cancer Incidence After Colonoscopy at Ages 45-49 or 50-54 Years
- Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years
- Predicting Advanced Neoplasia at Colonoscopy in a Diverse Population With the National Cancer Institute Colorectal Cancer Risk-Assessment Tool
- Real-Time Optical Biopsy of Colon Polyps With Narrow Band Imaging in Community Practice Does Not Yet Meet Key Thresholds for Clinical Decisions
- Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer
- Projected National Impact of Colorectal Cancer Screening on Clinical and Economic Outcomes and Health Services Demand
- Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis